These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17367583)

  • 1. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
    Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
    Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
    Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
    Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
    Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
    Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study.
    Babiloni C; Benussi L; Binetti G; Cassetta E; Dal Forno G; Del Percio C; Ferreri F; Ferri R; Frisoni G; Ghidoni R; Miniussi C; Rodriguez G; Romani GL; Squitti R; Ventriglia MC; Rossini PM
    Ann Neurol; 2006 Feb; 59(2):323-34. PubMed ID: 16358334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.
    Barabash A; Marcos A; Ancín I; Vázquez-Alvarez B; de Ugarte C; Gil P; Fernández C; Encinas M; López-Ibor JJ; Cabranes JA
    Neurobiol Aging; 2009 Aug; 30(8):1254-64. PubMed ID: 18078695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
    Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
    Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment.
    Zulli R; Nicosia F; Borroni B; Agosti C; Prometti P; Donati P; De Vecchi M; Romanelli G; Grassi V; Padovani A
    J Am Geriatr Soc; 2005 Dec; 53(12):2135-9. PubMed ID: 16398898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of APOE genotypes in a memory clinic cohort.
    van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
    Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.
    Visser PJ; Verhey FR
    Psychol Med; 2008 Jan; 38(1):113-22. PubMed ID: 17451628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.